Interstitial lung disease recurrence on chemotherapy rechallenge in breast cancer: a nationwide Japanese database
database[Title] 2025-04-26
Summary:
CONCLUSION: A notable ILD recurrence rate was observed in breast cancer patients after a cancer-directed therapy rechallenge, highlighting the need for cautious treatment planning and personalised strategies to balance cancer control while mitigating ILD risk.